Filing
Spy
Filing
Spy
Home
About
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2017 Q2
24 of 25 quarters
Total Value
$12.18M
Total Shares
949.8K
Net Share Change
+949.8K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Miller Value Partners
$12.18M
949.8K
0.5%
NEW
Miller Value Partners
$12.18M
949.8K shares
NEW
HALO — Halozyme Therapeutics Inc - FilingSpy